The nation of Zimbabwe has declined a major American healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive biological samples.
The decision came to light following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government representative later clarified that the United States was demanding access to genetic material for scientific study and profit while was not willing to guarantee the resulting advantages from future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for further dialogue to secure a agreement agreeable to both sides so the country's vital HIV programme can be sustained.
Broader Context
This development follows a comparable case in Kenya, where a court suspended a related deal with the US following concerns were raised about the security of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to enhance transparency and accountability.
Based on reports, 16 African countries have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our people if a future pandemic emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to ongoing discussions with our US partners on how future collaboration could be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Response
A leading public health body stated it acknowledged the official position, but suggested that negotiations must proceed given that much of the country's HIV programmes depended on foreign aid.
"If technical issues arise, including those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group added.
The halted deal emphasises the complex debate between receiving much-needed foreign assistance and protecting local interests in an increasingly data-driven world.